Although numerous serum-based biomarkers have been discovered and evaluated in the past decade, only the CA125 and HE4 biomarkers have been proven to be effective in predicting different types of epithelial ovarian cancer [36,37]. The gene discussed is WFDC2; the disease is ovarian carcinoma.